MORPHINE SULFATE INJECTION DIN 02500701
Health Canada record
| Active ingredient(s) | MORPHINE SULFATE 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular; Subcutaneous |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N02AA01 MORPHINE |
| Original market date | 29-Apr-2021 |
| Current status date | 29-Apr-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MORPHINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02019930 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | MORPHINE SULFATE 10 MG | Marketed |
| 02019957 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | MORPHINE SULFATE 60 MG | Marketed |
| 02019965 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | MORPHINE SULFATE 100 MG | Marketed |
| 02019949 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | MORPHINE SULFATE 30 MG | Marketed |
| 00617288 | MORPHINE HP 50 | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 50 MG | Marketed |
| 02021048 | MORPHINE LP EPIDURAL | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 1 MG | Marketed |
| 02021056 | MORPHINE LP EPIDURAL | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 0.5 MG | Marketed |
| 00392588 | MORPHINE SULFATE INJ 10MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 10 MG | Marketed |
| 00392561 | MORPHINE SULFATE INJ 15MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 15 MG | Marketed |
| 02014297 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | MORPHINE SULFATE 30 MG | Marketed |
| 02015439 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | MORPHINE SULFATE 15 MG | Marketed |
| 02014327 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | MORPHINE SULFATE 200 MG | Marketed |
| 02014319 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | MORPHINE SULFATE 100 MG | Marketed |
| 02014300 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | MORPHINE SULFATE 60 MG | Marketed |
| 02014211 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | MORPHINE SULFATE 10 MG | Marketed |
| 02014203 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | MORPHINE SULFATE 5 MG | Marketed |
| 02014238 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | MORPHINE SULFATE 20 MG | Marketed |
| 02014254 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | MORPHINE SULFATE 30 MG | Marketed |
| 00594652 | STATEX | KNIGHT THERAPEUTICS INC. | Tablet | MORPHINE SULFATE 5 MG | Marketed |
| 00594644 | STATEX | KNIGHT THERAPEUTICS INC. | Tablet | MORPHINE SULFATE 10 MG | Marketed |
| 02009765 | M.O.S. SULPHATE 10MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | MORPHINE SULFATE 10 MG | Cancelled Post Market |
| 02009749 | M.O.S. SULPHATE 25MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | MORPHINE SULFATE 25 MG | Cancelled Post Market |
| 02009706 | M.O.S. SULPHATE 50MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | MORPHINE SULFATE 50 MG | Cancelled Post Market |
| 02009773 | M.O.S. SULPHATE 5MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | MORPHINE SULFATE 5 MG | Cancelled Post Market |
| 00869325 | MORPHINE EXTRA-FORTE | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 50 MG | Cancelled Post Market |
| 00869317 | MORPHINE FORTE | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 25 MG | Cancelled Post Market |
| 00676411 | MORPHINE HP 25 - 25MG/ML | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 25 MG | Cancelled Post Market |
| 01980696 | MORPHINE SULFATE INJ 1MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 1 MG | Cancelled Post Market |
| 01964437 | MORPHINE SULFATE INJ 2MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 2 MG | Cancelled Post Market |
| 01964429 | MORPHINE SULFATE INJ 5MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | MORPHINE SULFATE 5 MG | Cancelled Post Market |
| 00649619 | MORPHINE SULFATE INJECTION USP | ICU MEDICAL CANADA INC | Solution | MORPHINE SULFATE 5 MG | Cancelled Post Market |
| 00850330 | MORPHINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 15 MG | Cancelled Post Market |
| 00850314 | MORPHINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 2 MG | Cancelled Pre Market |
| 00850322 | MORPHINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 10 MG | Cancelled Post Market |
| 00636908 | MORPHINE SULFATE INJECTION USP | ICU MEDICAL CANADA INC | Solution | MORPHINE SULFATE 1 MG | Cancelled Post Market |
| 00885509 | MORPHINE SULPHATE INJ 1MG/ML BP | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | MORPHINE SULFATE 1 MG | Cancelled Post Market |
| 02022672 | MORPHINE SULPHATE INJECTION B.P. 25MG/ML | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | MORPHINE SULFATE 25 MG | Cancelled Post Market |
| 02003759 | MORPHINE SULPHATE INJECTION BP 2MG/ML | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | MORPHINE SULFATE 2 MG | Cancelled Post Market |
| 02010380 | MORPHINE SULPHATE INJECTION, USP | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | MORPHINE SULFATE 25 MG | Cancelled Post Market |
| 02009897 | MORPHINE SULPHATE INJECTION, USP LIQ50MG/ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | MORPHINE SULFATE 50 MG | Cancelled Post Market |
| 02010364 | MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | MORPHINE SULFATE 1.1 MG | Cancelled Post Market |
| 01949047 | MORPHINE-EPD | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 0.5 MG | Cancelled Post Market |
| 01949055 | MORPHINE-EPD | PFIZER CANADA ULC | Solution | MORPHINE SULFATE 1 MG | Cancelled Post Market |
| 02014173 | MS IR SUP 30MG | PURDUE PHARMA | Suppository | MORPHINE SULFATE 30 MG | Cancelled Post Market |
| 02014246 | MS IR SUP 10MG | PURDUE PHARMA | Suppository | MORPHINE SULFATE 10 MG | Cancelled Post Market |
| 02014262 | MS IR SUP 20MG | PURDUE PHARMA | Suppository | MORPHINE SULFATE 20 MG | Cancelled Post Market |
| 01988743 | ORAMORPH SR TABLETS 100MG | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet (Extended-Release) | MORPHINE SULFATE 100 MG | Cancelled Post Market |
| 01988727 | ORAMORPH SR TABLETS 30MG | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet (Extended-Release) | MORPHINE SULFATE 30 MG | Cancelled Post Market |
| 01988735 | ORAMORPH SR TABLETS 60MG | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet (Extended-Release) | MORPHINE SULFATE 60 MG | Cancelled Post Market |
| 00705799 | STATEX DPS 50MG/ML | PALADIN PHARMA INC. | Drops | MORPHINE SULFATE 50 MG | Cancelled Post Market |
| 00621935 | STATEX DROPS 20MG/ML | PALADIN PHARMA INC. | Drops | MORPHINE SULFATE 20 MG | Cancelled Post Market |
| 00596965 | STATEX SUPPOSITORIES 20MG | PALADIN PHARMA INC. | Suppository | MORPHINE SULFATE 20 MG | Cancelled Post Market |
| 00639389 | STATEX SUPPOSITORIES 30MG | PALADIN PHARMA INC. | Suppository | MORPHINE SULFATE 30 MG | Cancelled Post Market |
| 00632228 | STATEX SUPPOSITORIES 5MG | PALADIN PHARMA INC. | Suppository | MORPHINE SULFATE 5 MG | Cancelled Post Market |
| 00647217 | STATEX SYRUP 10MG/ML | PALADIN PHARMA INC. | Syrup | MORPHINE SULFATE 10 MG | Cancelled Post Market |
| 00591467 | STATEX SYRUP 1MG/ML | PALADIN PHARMA INC. | Syrup | MORPHINE SULFATE 1 MG | Cancelled Post Market |
| 00591475 | STATEX SYRUP 5MG/ML | PALADIN PHARMA INC. | Syrup | MORPHINE SULFATE 5 MG | Cancelled Post Market |
| 00594636 | STATEX TABLET 25MG | PALADIN PHARMA INC. | Tablet | MORPHINE SULFATE 25 MG | Cancelled Post Market |
| 00675962 | STATEX TABLETS 50MG | PALADIN PHARMA INC. | Tablet | MORPHINE SULFATE 50 MG | Cancelled Post Market |
| 00632201 | STATEX-SUPPOSITORIES 10MG | PALADIN PHARMA INC. | Suppository | MORPHINE SULFATE 10 MG | Cancelled Post Market |
International API supply for MORPHINE SULFATE
4 active FDA Drug Master Files.
Request a quote for MORPHINE SULFATE INJECTION